Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» AstraZeneca Remains Committed To Development Of ZS-9 Despite Letter From FDA
AstraZeneca Remains Committed To Development Of ZS-9 Despite Letter From FDA
AstraZeneca Remains Committed To Development Of ZS-9 Despite Letter From FDA
Submitted by
admin
on May 27, 2016 - 12:42pm
Source:
Yahoo/Benzinga
News Tags:
AstraZeneca
FDA
ZS-9
hyperkalaemia
ZS Pharma
Headline:
AstraZeneca Remains Committed To Development Of ZS-9 Despite Letter From FDA
Do Not Allow Advertisers to Use My Personal information
